Immunoassay Interference Blocker Market 2022 Global Projection By Key Players - Abcam plc, AMS Biotechnology (Europe) Limited, Aviva Systems Biology Corporation- Analysis and Forecast to 2031

Immunoassay Interference Blocker Market 2022-2031

The Immunoassay Interference Blocker Market is bound to grow robustly in the years to come. With smart technology and 5G being increasingly adopted, the healthcare vertical is witnessing a paradigm shift. These technologies can thus increase the convenience quotient (CQ), as abysmal disruption happens in the patients' lives. This convenience quotient would be the trend running in the healthcare vertical shortly.

As per Persistence Market Research's latest revised industry analysis, the global immunoassay interference blocker market was valued at US$ 223 Mn in 2020, and is expected to exhibit a CAGR of 6.7% over the forecast period (2022-2031).

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/24343

Substances that modify quantifiable concentration of analytes or change antibody binding can conceivably result in immunoassay interference. Prevalence of interference is usually less in assays holding blocking agents, which counteract or inhibit the interference. Detection of interference may involve usage of a different assay, or quantification before and after treatment with supplementary blocking reagents.

Growing prevalence of chronic diseases and increasing aging population across the world are factors that are expected to surge the need for biochemical testing for the management of chronic diseases. Increase in aging population is likely to escalate demand for diagnostic kits and reagents for the detection of age-related as well as other chronic conditions. This is expected to drive the immunoassay interference blocker market over the forecast period of 2021 to 2031.

Governments around the world are supporting the growth of specialty medical diagnostic reagents, which further drives research & development. Immunoassay interference blocker kits and reagents play a vital role in preventing unnecessary interference generated while preforming an immunoassay-based disease detection test. Hence, an increase in growth of immunoassay interference blockers has been witnessed due to rising government support and funding.

Key manufacturers of immunoassay interference blockers have been focusing on expansion and new product launch programs to increase their consumer base in different geographies.

In 2019, Bio Rab Laboratories announced the launch of an innovative test to aid in the diagnosis of Lyme disease, with the FDA clearance of the bioplex 2200 Lyme total assay.
In 2021, Thermofisher Scientific planned for its manufacturing site expansion in the region of Mebane, N.C. USA.

Company Profiles:

Abcam plc
AMS BioApplication (Europe) Limited
Aviva Systems Biology Corporation
Bio-Rad Laboratories, Inc.
Meridian Bioscience, Inc.
Roche Diagnostics GmbH
Rockland Immunochemicals, Inc.
Scantibodies Laboratory, Inc.
Thermo Fisher Scientific

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/24343

Key Takeaways from Market Study

Antibody interference blockers hold the largest market share as compared to other products, expanding at a CAGR of 6.4%. A similar trend is expected to continue, primarily due to their high efficiency and reliable assay outcomes.

The application segment is led by antibody capture assays with a share of 39.8% in 2020, owing to high, precise, and accurate results with least interference obtained via immunoassay interference blockers.

Academic and research institutes dominated the end user segment with a share of around 39.5% in 2020. This segment is expected to grow two-fold by the end of 2031 due to increasing usage of immunoassay interference blockers in research activities to introduce novel applications.

By region, North America is slated to be the largest regional market with a value share of 33.3% at the end of the forecast period, due to constant clinical efforts to establish advanced diagnostics biologics and new drug discovery in the region.

"Increasing healthcare R&D spending and government support, continual technological advancements, and growing demand for better diagnosis are boosting demand for immunoassay interference blockers," says an analyst of Persistence Market Research.

Impact of Market Consolidation

Considering consolidation activities in the global market, strategic focus on novel product development and research based on advanced immunoassay interference blockers are some of the key growth strategies by market players. Prominent players are strengthening their product ranges through acquisitions and reaching out to key as well as emerging markets.

For instance:

In April 2020, Bio Rad Laboratories, Inc. announced the commercial launch of its SARS-CoV-2 Total Ab test, a blood-based immunoassay kit to help determine if an individual has developed antibodies to SARS-CoV-2, the virus associated with COVID-19 disease.

The research study is based on the product (antibody interference blockers, detection interference blockers, and surface interference blockers), application (sandwich immunoassays, antibody capture assays, competitive ELISA, and others) and end user (biotechnology companies, contract research organizations, academic and research institutes, and molecular diagnostics companies), across seven key regions of the world.

Major Highlights of the Immunoassay Interference Blocker Market Report:

The Immunoassay Interference Blocker Market analysis report offers an in-depth study of the potential market growth opportunities and challenges.

The report dives deeper into the market and explains the dynamic factors bolstering market growth.

The report deeply assesses the current, historical market size, market share, and revenue growth rates to offer accurate market projections for the forecast period.

The report analyzes the Immunoassay Interference Blocker Market presence across major regions of the world.

It determines the production & consumption capacities and demand & supply dynamics of each regional market.

The report further illustrates the intense competition among the key market players and highlights their effective business expansion plans and strategies.

It provides company overview and SWOT analysis of each of the market players.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/24343

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About PersistenceMarketResearch:

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against reputed organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

This release was published on openPR.